Analyst Ratings for Horizon Therapeutics (HZNP) [Buys]
HZNP Rating Summary
HZNP Price Target Summary
- Highest: $116.50 (Jefferies)
- Lowest: $116.50 (Jefferies)
- Average: $116.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$116.50 (+0.2%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
Avg. $ Target:
$116.50 (+0.2%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2022 | Oppenheimer » Updated 11/3/2022 |
Leland Gershell | New Coverage | Outperform (N/A) |
92.00 (90.00) |
100.76 (116.30) |
15.42% | Details |
| 11/19/2021 | Goldman Sachs » Updated 8/3/2022 |
Madhu Kumar | Upgrade | Buy (Neutral) |
144.00 (164.00) |
108.08 (116.30) |
7.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
